Natco Pharma
BSE: 524816
|
NSE: NATCOPHARM
Natco Pharma
(CIN: L24230TG1981PLC003201)
operates in the Pharmaceuticals industry and has been listed in the stock market since 11 Apr 1995.
It currents trades on NSE with symbol NATCOPHARM and on BSE with scrip code 524816.
The registered office of the company is Natco House, Road No 2, Banjara Hills, Hyderabad, Telangana - 500033.
The management team of Natco Pharma is led by VENKAIAH CHOWDARY NANNAPANENI who is the Executive Director-Chairperson-MD. Other members of the management team consist of RAJEEV NANNAPANENI (Designation:Executive Director-CEO), SIVARAMAKRISHNA PRASAD POTLURI (Designation:Executive Director), LINGARAO DONTHINENI (Designation:Executive Director), AGNIHOTRA DAKSHINA MURTY CHAVALI (Designation:Non-Executive - Independent Director), DRONADULA VIJAYA BHASKAR (Designation:Non-Executive - Independent Director), LAKSHMINARAYANA BOLISETTY (Designation:Non-Executive - Independent Director), SUMA KANTIPUDI (Designation:Non-Executive - Independent Director), NITIN JAIN (Designation:Non-Executive - Independent Director), Amit Parekh (Designation:Chief Financial Officer), Chekuri Venkat Ramesh (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Natco Pharma is as below -
The registered office of the company is Natco House, Road No 2, Banjara Hills, Hyderabad, Telangana - 500033.
The management team of Natco Pharma is led by VENKAIAH CHOWDARY NANNAPANENI who is the Executive Director-Chairperson-MD. Other members of the management team consist of RAJEEV NANNAPANENI (Designation:Executive Director-CEO), SIVARAMAKRISHNA PRASAD POTLURI (Designation:Executive Director), LINGARAO DONTHINENI (Designation:Executive Director), AGNIHOTRA DAKSHINA MURTY CHAVALI (Designation:Non-Executive - Independent Director), DRONADULA VIJAYA BHASKAR (Designation:Non-Executive - Independent Director), LAKSHMINARAYANA BOLISETTY (Designation:Non-Executive - Independent Director), SUMA KANTIPUDI (Designation:Non-Executive - Independent Director), NITIN JAIN (Designation:Non-Executive - Independent Director), Amit Parekh (Designation:Chief Financial Officer), Chekuri Venkat Ramesh (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Natco Pharma is as below -
Volume: 98,506.00
M. Cap: 16,180.79
P/E: 11.41
Prev. Close: 893.95
Day
52 Wk
Volume: 8,08,487.00
M. Cap: 16,185.27
P/E: 11.41
Prev. Close: 893.60
Day
52 Wk
Stock Price Chart
F&O Data
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 8,85,15,126 | 49.42 |
| Pledge | 0 | 0.00 |
| Foreign Institutions | 3,11,15,988 | 17.37 |
| Financial Institutions | 97,01,512 | 5.42 |
| NBFC and Mutual Funds | 30,73,831 | 1.72 |
| Others | 4,97,77,244 | 27.78 |
| Total | 18,21,83,701 | 101.71 |
Financial Data
Consolidated
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 4,429.50 | 3,998.80 | 2,707.10 |
| Operating Profit | 2,550.50 | 1,879.50 | 1,040.20 |
| Other Income | 354.50 | 128.10 | 104.60 |
| Interest | 23.90 | 19.20 | 14.50 |
| Depreciation | 235.20 | 186.80 | 163.80 |
| Profit Before Tax | 2,291.40 | 1,673.50 | 861.90 |
| Tax | 408.00 | 285.20 | 146.60 |
| Profit After Tax | 1,883.40 | 1,388.30 | 715.30 |
| Share Capital | 35.80 | 35.80 | 36.50 |
| Reserves | 7,571.20 | 5,817.30 | 4,837.30 |
| Net Worth | 7,607.00 | 5,853.10 | 4,873.80 |
| Loans | 349.60 | 446.10 | 253.70 |
| Gross Block | 4,016.10 | 3,603.20 | 3,375.10 |
| Investments | 473.60 | 539.40 | 392.30 |
| Cash | 2,176.00 | 952.90 | 546.30 |
| Debtors | 1,246.60 | 1,188.90 | 856.10 |
| Net Working Capital | 4,564.90 | 3,131.70 | 2,244.00 |
| Operating Profit Margin (%) | 57.58 | 47.00 | 38.42 |
| Net Profit Margin (%) | 42.52 | 34.72 | 26.42 |
| EPS | 105.33 | 77.56 | 39.19 |
| Dividend (%) | 300.00 | 475.00 | 275.00 |
| Dividend Payout | 107.50 | 170.20 | 100.40 |
Standalone
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 4,094.50 | 3,568.90 | 2,351.00 |
| Operating Profit | 2,465.60 | 1,741.70 | 930.20 |
| Other Income | 321.30 | 104.70 | 85.50 |
| Interest | 19.60 | 14.50 | 8.60 |
| Depreciation | 220.00 | 171.90 | 150.90 |
| Profit Before Tax | 2,226.00 | 1,555.30 | 770.70 |
| Tax | 375.60 | 248.70 | 133.60 |
| Profit After Tax | 1,850.40 | 1,306.60 | 637.10 |
| Share Capital | 35.80 | 35.80 | 36.50 |
| Reserves | 7,298.10 | 5,556.50 | 4,665.50 |
| Net Worth | 7,333.90 | 5,592.30 | 4,702.00 |
| Loans | 344.80 | 441.00 | 248.10 |
| Gross Block | 3,783.70 | 3,359.50 | 3,157.10 |
| Investments | 855.10 | 741.70 | 657.50 |
| Cash | 1,856.90 | 864.90 | 412.00 |
| Debtors | 1,178.20 | 1,076.60 | 793.10 |
| Net Working Capital | 4,081.50 | 2,871.00 | 1,996.00 |
| Operating Profit Margin (%) | 60.22 | 48.80 | 39.57 |
| Net Profit Margin (%) | 45.19 | 36.61 | 27.10 |
| Earning Per Share (Rs) | 103.37 | 72.99 | 34.91 |
| Dividend (%) | 300.00 | 475.00 | 275.00 |
| Dividend Payout | 107.50 | 170.20 | 100.40 |
Dividend Declared (₹)
The company has declared dividend 5 times between 27 Nov 2024 and 18 Feb 2026, totaling Rs. 6.00 so far. The most recent dividend was declared on 18 Feb 2026 for Rs. 1.5.
Financial Data Graph
The peers of Natco Pharma are LUPIN, IOLCP and STAR. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.